Vaccination against Tick Borne Encephalitis

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60162694%3AG16__%2F02%3A00000835" target="_blank" >RIV/60162694:G16__/02:00000835 - isvavai.cz</a>

Alternative codes found

RIV/60162694:G38__/02:00000835

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Vaccination against Tick Borne Encephalitis

Original language description

The study monitored antibody response and safety at 187 volunteers vaccinated by vaccine Encepur in rapid schedule (day 0-7-21). Antibody response was recorded in months 1, 15, 16, 27 and 39. The vaccine was clinically very good tolerated, there was recorded no serious adverse event. 97.5% of person obtain adequate protective titre of antibodies at month 1. An overage titre of antibodies was protective (178.8 VIEU/ml) at month 15. The after vaccination is direct relative by age. For person younger 35 years are possible to indicate revaccination at month 18. For older person are more convenient to revaccinate them at month 12. The vaccine is very immunogenic also at rapid vaccination schedule.

Czech name

—

Czech description

—

Type

D - Article in proceedings

CEP classification

FF - ENT (ie. ear, nose, throat), ophthalmology, dentistry

OECD FORD branch

—

Project

—

Continuities

Z - Vyzkumny zamer (s odkazem do CEZ)

Publication year

2002

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Article name in the collection

Sborník 18. Stredoslovenske lekárske dni

ISBN

—

ISSN

—

e-ISSN

—

Number of pages

2

Pages from-to

—

Publisher name

Spolok lekárov

Place of publication

Martin

Event location

Martin

Event date

May 23, 2002

Type of event by nationality

—

UT code for WoS article

—